NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Shi, Yan Chuan ^a   Lin, Shu ^a   Wong, Iris P L ^a   Baldock, Paul A ^a,b   Aljanova, Aygul ^a   Enriquez, Ronaldo F ^a   Castillo, Lesley ^a   Mitchell, Natalie F ^a   Ye, Ji Ming ^a   Zhang, Lei ^a   Macia, Laurence ^a   Yulyaningsih, Ernie ^a   Nguyen, Amy D ^a   Riepler, Sabrina J ^a   Herzog, Herbert ^a,b   Sainsbury, Amanda ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE I; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; PROOPIOMELANOCORTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE DEVELOPMENT; BONE MINERAL; CONTROLLED STUDY; CORTICAL BONE; ENERGY BALANCE; FEMALE; FOOD INTAKE; GENE DELETION; HOMEOSTASIS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; INHIBITION KINETICS; KNOCKOUT MOUSE; LIPOGENESIS; LIVER PARENCHYMA; MALE; MOUSE; NEGATIVE FEEDBACK; NERVE CELL; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SEX DIFFERENCE; SKELETAL MUSCLE; TRABECULAR BONE; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; BONE AND BONES; DNA PRIMERS; FEMALE; HOMEOSTASIS; MALE; MICE; MICE, KNOCKOUT; NEURONS; RECEPTORS, NEUROPEPTIDE Y;

MUS;

EID: 77955331814     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011361     Document Type: Article

References (57)

1. Stanley BG, Anderson KC, Grayson MH, Leibowitz SF (1989) Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats. Physiol Behav 46: 173-177.
2. Kotz CM, Briggs JE, Grace MK, Levine AS, Billington CJ (1998) Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. Am J Physiol 275: R471-477.
3. Baraban SC (1998) Neuropeptide Y and limbic seizures. Reviews in the Neurosciences 9: 117-128.
4. Lin S, Boey D, Herzog H (2004) NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38: 189-200.
5. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, et al. (2002) Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418: 650-654.
6. Dowell P, Hu Z, Lane M (2005) Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Annual Review of Biochemistry 74: 515-534.
7. Hahn TM, Breininger JF, Baskin DG, Schwartz MW (1998) Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1: 271-272.
8. Ellacott KL, Cone RD (2004) The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Progres in Hormone Research 59: 395-408.
9. Blomqvist AG, Herzog H (1997) Y-receptor subtypes-how many more? Trends Neurosci 20: 294-298.
10. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, et al. (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti- related protein. Science 278: 135-138.
11. Acuna-Goycolea C, Tamamaki N, Yanagawa Y, Obata K, van den Pol AN (2005) Mechanisms of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. The Journal of Neuroscience 25: 7406-7419.
12. Beck B, Burlet A, Bazin R, Nicholas JP, Burlet C (1993) Elevated neuropeptide Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating. Journal of Nutrition 123: 1168-1172.
13. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS (1991) Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proceedings of the National Academy of Sciences of the United States of America 88: 10931-10935.
14. McKibbon PE, Cotton SJ, McMillan S, Holloway B, Mayers R, et al. (1991) Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Possible relationship to obesity and neuroendocrine disturbances. Diabetes 40: 1423-1429.
15. Williams G, Steel JH, Cardoso H, Ghatei MA, Lee YC, et al. (1988) Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes 37: 763-772.
16. Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381: 415-421.
17. Erickson JC, Hollopeter G, Palmiter RD (1996) Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274: 1704-1707.
18. Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B (1997) Adrenalec- tomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes 46: 209-214.
19. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133: 1753-1758.
20. Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML (1996) Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Endocrinology 137: 3-12.
21. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS (1994) Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 266: R1765-1770.
22. Parker RMC, Herzog H (1999) Regional distribution of Y-receptor subtype mRNAs in rat brain. European Journal of Neuroscience 11: 1431-1448.
23. Fetissov SO, Byrne LC, Hassani H, Ernfors P, Hokfelt T (2004) Characteriza- tion of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus. Journal of Comparative Neurology 470: 256-265.
24. Leibowitz SF, Alexander JT (1991) Analysis of neuropeptide Y-induced feeding: dissociation of Y1 and Y2 receptor effects on natural meal patterns. Peptides 12: 1251-1260.
25. King PJ, Williams G, Doods H, Widdowson PS (2000) Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release. Eur J Pharmacol 396: R1-3.
26. Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, et al. (2002) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci U S A 99: 8938-8943.
27. Sainsbury A, Schwarzer C, Couzens M, Herzog H (2002) Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51: 3420-3427.
28. Broberger C, Landry M, Wong H, Walsh JN, Hokfelt T (1997) Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro- opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypotha- lamic arcuate nucleus. Neuroendocrinology 66: 393-408.
29. Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, et al. (2005) Hypothalamic control of bone formation: distinct actions of leptin and Y2 receptor pathways. Journal of Bone and Mineral Research 20: 1851-1857.
30. Baldock PA, Allison S, McDonald MM, Sainsbury A, Enriquez RF, et al. (2006) Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 21: 1600-1607.
31. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, et al. (2002) Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109: 915-921.
32. Baldock PA, Lee NJ, Driessler F, Lin S, Allison S, et al. (2009) Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One 4: e8415.
33. Sainsbury A, Baldock P, Schwarzer C, Ueno H, Enriquez R, et al. (2003) Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Molecular and Cellular Biology 23: 5225-5223.
34. Lin S, Lin EJ, Boey D, Lee NJ, Slack K, et al. (2007) Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways. Endocrinology 148: 2056-2065.
35. Franklin KBP, Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates.
36. Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review. Metabolism 37: 287-301.
37. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634.
38. McLean JA, Tobin G (1987) Animal and human Calorimetry. 352 p.
39. Ye JM, Iglesias MA, Watson DG, Ellis B, Wood L, et al. (2003) PPARalpha/ gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol Endocrinol Metab 284: E531-540.
40. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
41. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, et al. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484.
42. Boey D, Lin S, Karl T, Baldock P, Lee N, et al. (2006) Peptide YY ablation in mice leads to the development of hyperinsulinemia and obesity. Diabetologia 49: 1360-1370.
43. Boey D, Lin S, Enriquez RF, Lee NJ, Slack K, et al. (2008) PYY transgenic mice are protected against diet-induced and genetic obesity. Neuropeptides 42: 19-30.
44. Allison SJ, Baldock P, Sainsbury A, Enriquez R, Lee NJ, et al. (2006) Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy- induced bone loss in adult mice. J Biol Chem 281: 23436-23444.
45. Baran K, Preston E, Wilks D, Cooney GJ, Kraegen EW, et al. (2002) Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Diabetes 51: 152-158.
46. Pedrazzini T, Seydoux J, Kunstner P, Aubert JF, Grouzmann E, et al. (1998) Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4: 722-726.
47. Pralong FP, Gonzales C, Voirol MJ, Palmiter RD, Brunner HR, et al. (2002) The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. Faseb J 16: 712-714.
48. Naveilhan P, Svensson L, Nystrom S, Ekstrand AJ, Ernfors P (2002) Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation. Peptides 23: 1087-1091.
49. Playford RJ, Cox HM (1996) Peptide YY and neuropeptide Y: two peptides intimately involved in electrolyte homeostasis. Trends Pharmacol Sci 17: 436-438.
50. Tasan RO, Nguyen NK, Weger S, Sartori SB, Singewald N, et al. (2010) The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 30: 6282-6290.
51. Marin MT, Cruz FC, Planeta CS (2007) Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats. Physiol Behav 90: 29-35.
52. Zafar HM, Pare WP, Tejani-Butt SM (1997) Effect of acute or repeated stress on behavior and brain norepinephrine system in Wistar-Kyoto (WKY) rats. Brain Res Bull 44: 289-295.
53. Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, et al. (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13: 803-811.
54. Redrobe JP, Dumont Y, Herzog H, Quirion R (2004) Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci 22: 159-166.
55. Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, et al. (2003) Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18: 143-148.
56. Heilig M (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38: 213-224.
57. Sainsbury A, Bergen HT, Boey D, Bamming D, Cooney GJ, et al. (2006) Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice. Diabetes 55: 19-26.